Madison-based Exact Sciences will be acquired by Abbott Laboratory for roughly $23 billion in a deal that was announced Nov.

Abbott Laboratories announced a $21 billion deal Thursday morning to acquire Exact Sciences, the maker of Cologuard — its ...

Abbott announced on Thursday, Nov. 20 it plans to buy Exact Sciences, a Madison-based maker of cancer screening and ...

Founded near Boston in 1995, the company grew to become a biotech giant largely on the strength of its Cologuard cancer ...

The company will maintain its presence in Madison and CEO Kevin Conroy will remain “in an advisory role,” said Zach Brandon, ...

Abbott Laboratories agreed to acquire cancer-screening company Exact Sciences Corp., in a deal with a total equity value of ...

Global healthcare leader Abbott announced Thursday that it has reached a $23 billion deal to acquire Exact Sciences.

Abbott agrees to acquire Exact Sciences for an estimated value up to $23 billion. The acquisition will include Exact Sciences' cancer ...

MADISON (WKOW) -- Abbott announced it will acquire Exact Sciences for an approximate enterprise value of $23 billion. Exact ...

Abbott will acquire Madison-based cancer diagnostics company Exact Sciences in a $21 billion deal, expanding its global diagnostics portfolio.

Abbott Laboratories, headquartered in north suburban Abbott Park, will acquire Madison, Wisconsin-based Exact Sciences, the ...